Does OLANZAPINE Cause Cerebral atrophy? 52 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Cerebral atrophy have been filed in association with OLANZAPINE (Olanzapine). This represents 0.1% of all adverse event reports for OLANZAPINE.
52
Reports of Cerebral atrophy with OLANZAPINE
0.1%
of all OLANZAPINE reports
1
Deaths
27
Hospitalizations
How Dangerous Is Cerebral atrophy From OLANZAPINE?
Of the 52 reports, 1 (1.9%) resulted in death, 27 (51.9%) required hospitalization, and 18 (34.6%) were considered life-threatening.
Is Cerebral atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does OLANZAPINE Cause?
Drug ineffective (5,139)
Weight increased (3,588)
Off label use (3,256)
Toxicity to various agents (3,175)
Somnolence (2,612)
Sedation (2,130)
Suicide attempt (2,116)
Confusional state (1,898)
Condition aggravated (1,810)
Overdose (1,765)
What Other Drugs Cause Cerebral atrophy?
FINGOLIMOD (87)
VALPROIC ACID (84)
PHENYTOIN (58)
METHOTREXATE (55)
LEVETIRACETAM (54)
CYCLOPHOSPHAMIDE (52)
CARBIDOPA\LEVODOPA (50)
VALPROATE (50)
OCRELIZUMAB (48)
INTERFERON BETA-1A (46)
Which OLANZAPINE Alternatives Have Lower Cerebral atrophy Risk?
OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE
OLANZAPINE vs OLAPARIB
OLANZAPINE vs OLARATUMAB
OLANZAPINE vs OLECLUMAB
OLANZAPINE vs OLIVE OIL\SOYBEAN OIL